Insight Into The Exercise Training Role In Preventing And Managing Non-Alcoholic Fatty Liver Disease

被引:0
|
作者
Abdelbasset, Walid Kamal [1 ]
机构
[1] Prince Sattam Bin Abdulaziz Univ, Dept Hlth & Rehabil Sci, Coll Appl Med Sci, Al Kharj, Saudi Arabia
关键词
exercise training; hepatic fat; high-intensity interval; moderate-intensity; NAFLD; LIFE-STYLE MODIFICATION; PHYSICAL-ACTIVITY; HEPATIC STEATOSIS; WEIGHT-LOSS; RESISTANCE;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is a major public health issue worldwide, where the economy is rising and people's lifestyles are changing rapidly. Those with NAFLD have fat deposits accumulation in their hepatocytes that are caused by factors other than alcohol and liver injury, such as obesity, diabetes, and metabolic disorders. To demonstrate comprehensive and technical references for prescribing exercise programs for NAFLD treatment, we have proposed this review to clarify the role of exercise in the management and prevention of NAFLD using several previous studies investigating the clinical efficiency of various therapeutic exercise modalities in NAFLD patients. Endurance and strengthening training should be done twice a week at least and ideally three times a week, with at least eight exercises targeting the groups of major muscles with a repetition of 10-15 times each exercise at a moderate to high intensity, according to universal commendations of 150 minutes a week moderate-intensity aerobic exercises. In addition, patients who are unable to participate in formal exercise programs should aim to reduce or break up their sedentary time by a few minutes of walking. Patients' exercise compliance and achievement of exercise goals should be closely monitored to ensure therapeutic effects.
引用
收藏
页码:6 / 9
页数:4
相关论文
共 50 条
  • [31] Exercise Training Does Not Enhance Diastolic Function In Non-alcoholic Fatty Liver Disease Patients
    Jones, Helen
    Wong, Christopher K.
    Burgess, Malcolm I.
    Pugh, Christopher J.
    George, Keith
    Umpleby, Margot
    Shojaee-Moradie, Fariba
    Kemp, Graham J.
    Cuthbertson, Daniel J.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2012, 44 : 725 - 725
  • [32] Non-alcoholic Fatty Liver Disease
    Tan, Hui-Hui
    Chang, Jason Pik-Eu
    PROCEEDINGS OF SINGAPORE HEALTHCARE, 2010, 19 (01) : 36 - 50
  • [33] Non-alcoholic fatty liver disease
    Angulo, P
    Lindor, KD
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 : S186 - S190
  • [34] Non-alcoholic fatty liver disease
    Powell, Elizabeth E.
    Wong, Vincent Wai-Sun
    Rinella, Mary
    LANCET, 2021, 397 (10290): : 2212 - 2224
  • [35] Non-alcoholic fatty liver disease
    Maurice, James
    Manousou, Pinelopi
    CLINICAL MEDICINE, 2018, 18 (03) : 245 - 250
  • [36] Non-alcoholic fatty liver disease
    Neuschwander-Tetri, Brent A.
    BMC MEDICINE, 2017, 15
  • [37] Non-alcoholic fatty liver disease
    Smith, Briohny W.
    Adams, Leon A.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2011, 48 (03) : 97 - 113
  • [38] Non-alcoholic fatty liver disease
    Carreras, MP
    Tortajada, GC
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2005, 97 (05) : 377 - 377
  • [39] Non-alcoholic fatty liver disease
    Bjornsson, Einar
    Angulo, Paul
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 (09) : 1023 - 1030
  • [40] Non-alcoholic fatty liver disease
    Cua, IHY
    George, J
    HOSPITAL MEDICINE, 2005, 66 (02): : 106 - 111